A cross-sectional survey on the early impact of COVID-19 on the uptake of decentralised trial methods in the conduct of clinical trials

A cross-sectional survey on the early impact of COVID-19 on the uptake of decentralised trial methods in the conduct of clinical trials

Abstract Background The COVID-19 pandemic significantly impacted the conduct of clinical trials through delay, interruption or cancellation. Decentralised methods in clinical trials could help to continue trials during a pandemic. This paper presents the results of an exploratory study conducted ear...

Full description

Bibliographic Details
Main Authors: Arnela Suman, Jasmijn van Es, Helga Gardarsdottir, Diederick E. Grobbee, Kimberly Hawkins, Megan A. Heath, Isla S. Mackenzie, Ghislaine van Thiel, Mira G. P. Zuidgeest, on behalf of the Trials@Home Consortium
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Trials
Subjects:
Decentralised trial methods
Digital health solutions
Decentralised clinical trials
COVID-19
Clinical trials
Online Access:https://doi.org/10.1186/s13063-022-06706-x

Internet

https://doi.org/10.1186/s13063-022-06706-x

Similar Items